Additionally, upregulated PPARβ/δ expression has been observed in the skin lesions of psoriasis and impaired atopic dermatitis, and inhibiting PPARβ/δ may offer therapeutic potential for diseases associated with hyperproliferation of epidermal keratinocytes [15,16,17]. The gene discussed is PPARD; the disease is atopic eczema.